Results vary by starting weight, metabolism, adherence, and dose
Given the smaller sample sizes available in non-European populations, we did not perform genome-wide association testing in these populations, and instead focused analyses on variants discovered as associated in the European GWAS
If you are pregnant, breastfeeding, have medical conditions, or taking medication, consult with your physician before using this product
While ~40% of Americans are obese , only ~ 5-10% currently are using GLP-1 drugs for weight loss, highlighting a significant runway for adoption as awareness, access, and supply improve
27 , e13211 (2022)